<p>资金雄厚的投资者对 Moderna（纳斯达克：MRNA）采取了看涨的态度，这一点市场参与者不应忽视。我们在 Benzinga 对公开期权记录的追踪揭示了今天这一重要举动。这些投资者的身份仍然未知，但在 MRNA 中如此大规模的举动通常暗示着一些重大事件即将发生。</p>
<p>我们今天的观察中发现，Benzinga 的期权扫描仪突出了 Moderna 的 10 个非凡期权活动。这一活动水平显得异常。</p>
<p>这些重量级投资者的整体情绪呈现分歧，60% 倾向于看涨，30% 看跌。在这些显著的期权中，有 4 个是看跌期权，总计 442,603 美元，6 个是看涨期权，总计 345,665 美元。</p>
<h3>预期价格变动</h3>
<p>考虑到这些合约的成交量和未平仓合约，鲸鱼们似乎在过去 3 个月内将 Moderna 的目标价格区间定在 22.0 美元到 39.0 美元之间。</p>
<h3>分析成交量与未平仓合约</h3>
<p>在今天的交易环境中，Moderna 期权的平均未平仓合约为 1508.67，总成交量达到 3,911.00。附图描绘了过去 30 天内 Moderna 高价值交易的看涨和看跌期权的成交量和未平仓合约的变化。</p>
<h3>Moderna 期权活动分析：过去 30 天</h3>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2025/1765821665_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="期权看涨图表" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2025/1765821665_0.png"/></p>
<h3>检测到的重要期权交易：</h3>
<table>
<thead>
<tr>
<th><strong>符号</strong></th>
<th><strong>看跌/看涨</strong></th>
<th><strong>交易类型</strong></th>
<th><strong>情绪</strong></th>
<th><strong>到期日</strong></th>
<th><strong>卖出价</strong></th>
<th><strong>买入价</strong></th>
<th><strong>价格</strong></th>
<th><strong>行权价</strong></th>
<th><strong>总交易价格</strong></th>
<th><strong>未平仓合约</strong></th>
<th><strong>成交量</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>MRNA</td>
<td>看跌</td>
<td>扫描</td>
<td>看跌</td>
<td>02/20/26</td>
<td>$2.31</td>
<td>$2.13</td>
<td>$2.32</td>
<td>$27.00</td>
<td>$347.9K</td>
<td>292</td>
<td>1.5K</td>
</tr>
<tr>
<td>MRNA</td>
<td>看涨</td>
<td>交易</td>
<td>看跌</td>
<td>01/21/28</td>
<td>$12.45</td>
<td>$11.9</td>
<td>$11.9</td>
<td>$27.00</td>
<td>$119.0K</td>
<td>458</td>
<td>100</td>
</tr>
<tr>
<td>MRNA</td>
<td>看涨</td>
<td>交易</td>
<td>看涨</td>
<td>06/18/26</td>
<td>$6.3</td>
<td>$6.0</td>
<td>$6.3</td>
<td>$28.00</td>
<td>$62.3K</td>
<td>1.2K</td>
<td>51</td>
</tr>
<tr>
<td>MRNA</td>
<td>看涨</td>
<td>交易</td>
<td>中性</td>
<td>02/20/26</td>
<td>$1.65</td>
<td>$1.48</td>
<td>$1.55</td>
<td>$35.00</td>
<td>$46.5K</td>
<td>632</td>
<td>303</td>
</tr>
<tr>
<td>MRNA</td>
<td>看涨</td>
<td>交易</td>
<td>看涨</td>
<td>09/18/26</td>
<td>$6.15</td>
<td>$5.75</td>
<td>$6.15</td>
<td>$32.00</td>
<td>$43.0K</td>
<td>175</td>
<td>70</td>
</tr>
</tbody>
</table>
<h3>关于 Moderna</h3>
<p>Moderna 是一家商业阶段的生物技术公司，成立于 2010 年，并于 2018 年 12 月首次公开募股。该公司的 mRNA 技术在其新冠疫苗中迅速得到验证，该疫苗于 2020 年 12 月在美国获得授权。截至 2025 年 8 月，Moderna 有 35 个 mRNA 开发候选药物处于临床研究阶段。其项目涵盖了广泛的治疗领域，包括传染病、肿瘤学、心血管疾病和罕见遗传疾病。</p>
<p>在对 Moderna 的期权交易进行全面审查后，我们将更详细地审视该公司。这包括对其当前市场状态和表现的评估。</p>
<h3>Moderna 目前的状况如何？</h3>
<ul>
<li>MRNA 的成交量为 3,654,858，价格上涨 0.81%，达到 29.7 美元。</li>
<li>RSI 指标暗示基础股票可能接近超买状态。</li>
<li>下一次财报预计将在 60 天内发布。</li>
</ul>
<h3>专家对 Moderna 的看法</h3>
<p>在过去 30 天内，共有 5 位专业分析师对该股票发表了看法，设定的平均目标价为 32.8 美元。</p>
<p><strong>在短短 20 天内将 1000 美元变成 1270 美元？</strong></p>
<p>一位拥有 20 年经验的期权交易员揭示了他的单行图表技术，显示何时买入和卖出。复制他的交易，平均每 20 天获得 27% 的利润。点击这里获取访问权限。
* RBC Capital 的一位分析师决定维持对 Moderna 的行业表现评级，目前目标价为 25 美元。
* 摩根士丹利的一位分析师继续维持对 Moderna 的均衡评级，目标价为 28 美元。
* Leerink Partners 的一位分析师维持对 Moderna 的表现不佳评级，目标价为 18 美元。
* Jefferies 的一位分析师谨慎地将其评级下调至持有，目标价为 30 美元。
* Piper Sandler 的一位分析师将其评级下调至超配，目标价为 63 美元。</p>
<p>交易期权涉及更大的风险，但也提供了更高的利润潜力。精明的交易者通过持续教育、战略交易调整、利用各种指标以及关注市场动态来降低这些风险。通过 Benzinga Pro 获取 Moderna 最新期权交易的实时警报。</p>

MRNA

<p>资金雄厚的投资者对 Moderna（纳斯达克代码：MRNA）表现出乐观情绪，显著的期权交易活动被检测到。Benzinga 的期权扫描仪突出了 10 个非凡的期权活动，其中 60% 为看涨，30% 为看跌。目标价格区间为 22.0 美元至 39.0 美元。Moderna 的股票上涨 0.81%，报 29.7 美元。分析师的评级各不相同，价格目标范围从 18 美元到 63 美元。作为一家生物技术公司，Moderna 目前有 35 个 mRNA 开发候选药物处于临床研究中。下一个财报预计将在 60 天内发布</p>

<p>Deep-pocketed investors have adopted a bullish approach towards Moderna (NASDAQ: MRNA), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MRNA usually suggests something big is about to happen.</p>
<div class="lb-trans"><p>资金雄厚的投资者对 Moderna（纳斯达克：MRNA）采取了看涨的态度，这一点市场参与者不应忽视。我们在 Benzinga 对公开期权记录的追踪揭示了今天这一重要举动。这些投资者的身份仍然未知，但在 MRNA 中如此大规模的举动通常暗示着一些重大事件即将发生。</p>
</div><p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options activities for Moderna. This level of activity is out of the ordinary.</p>
<div class="lb-trans"><p>我们今天的观察中发现，Benzinga 的期权扫描仪突出了 Moderna 的 10 个非凡期权活动。这一活动水平显得异常。</p>
</div><p>The general mood among these heavyweight investors is divided, with 60% leaning bullish and 30% bearish. Among these notable options, 4 are puts, totaling $442,603, and 6 are calls, amounting to $345,665.</p>
<div class="lb-trans"><p>这些重量级投资者的整体情绪呈现分歧，60% 倾向于看涨，30% 看跌。在这些显著的期权中，有 4 个是看跌期权，总计 442,603 美元，6 个是看涨期权，总计 345,665 美元。</p>
</div><h3>Expected Price Movements</h3>
<div class="lb-trans"><h3>预期价格变动</h3>
</div><p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $22.0 to $39.0 for Moderna over the last 3 months.</p>
<div class="lb-trans"><p>考虑到这些合约的成交量和未平仓合约，鲸鱼们似乎在过去 3 个月内将 Moderna 的目标价格区间定在 22.0 美元到 39.0 美元之间。</p>
</div><h3>Analyzing Volume &amp; Open Interest</h3>
<div class="lb-trans"><h3>分析成交量与未平仓合约</h3>
</div><p>In today's trading context, the average open interest for options of Moderna stands at 1508.67, with a total volume reaching 3,911.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Moderna, situated within the strike price corridor from $22.0 to $39.0, throughout the last 30 days.</p>
<div class="lb-trans"><p>在今天的交易环境中，Moderna 期权的平均未平仓合约为 1508.67，总成交量达到 3,911.00。附图描绘了过去 30 天内 Moderna 高价值交易的看涨和看跌期权的成交量和未平仓合约的变化。</p>
</div><h3>Moderna Option Activity Analysis: Last 30 Days</h3>
<div class="lb-trans"><h3>Moderna 期权活动分析：过去 30 天</h3>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2025/1765821665_0.png" alt="Options Call Chart" original-src="https://www.benzinga.com/files/images/story/2025/1765821665_0.png"/></p>
<h3>Significant Options Trades Detected:</h3>
<div class="lb-trans"><h3>检测到的重要期权交易：</h3>
</div><table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/20/26</td>
<td>$2.31</td>
<td>$2.13</td>
<td>$2.32</td>
<td>$27.00</td>
<td>$347.9K</td>
<td>292</td>
<td>1.5K</td>
</tr>
<tr>
<td>MRNA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/21/28</td>
<td>$12.45</td>
<td>$11.9</td>
<td>$11.9</td>
<td>$27.00</td>
<td>$119.0K</td>
<td>458</td>
<td>100</td>
</tr>
<tr>
<td>MRNA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$6.3</td>
<td>$6.0</td>
<td>$6.3</td>
<td>$28.00</td>
<td>$62.3K</td>
<td>1.2K</td>
<td>51</td>
</tr>
<tr>
<td>MRNA</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>02/20/26</td>
<td>$1.65</td>
<td>$1.48</td>
<td>$1.55</td>
<td>$35.00</td>
<td>$46.5K</td>
<td>632</td>
<td>303</td>
</tr>
<tr>
<td>MRNA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/18/26</td>
<td>$6.15</td>
<td>$5.75</td>
<td>$6.15</td>
<td>$32.00</td>
<td>$43.0K</td>
<td>175</td>
<td>70</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th><strong>符号</strong></th>
<th><strong>看跌/看涨</strong></th>
<th><strong>交易类型</strong></th>
<th><strong>情绪</strong></th>
<th><strong>到期日</strong></th>
<th><strong>卖出价</strong></th>
<th><strong>买入价</strong></th>
<th><strong>价格</strong></th>
<th><strong>行权价</strong></th>
<th><strong>总交易价格</strong></th>
<th><strong>未平仓合约</strong></th>
<th><strong>成交量</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>MRNA</td>
<td>看跌</td>
<td>扫描</td>
<td>看跌</td>
<td>02/20/26</td>
<td>$2.31</td>
<td>$2.13</td>
<td>$2.32</td>
<td>$27.00</td>
<td>$347.9K</td>
<td>292</td>
<td>1.5K</td>
</tr>
<tr>
<td>MRNA</td>
<td>看涨</td>
<td>交易</td>
<td>看跌</td>
<td>01/21/28</td>
<td>$12.45</td>
<td>$11.9</td>
<td>$11.9</td>
<td>$27.00</td>
<td>$119.0K</td>
<td>458</td>
<td>100</td>
</tr>
<tr>
<td>MRNA</td>
<td>看涨</td>
<td>交易</td>
<td>看涨</td>
<td>06/18/26</td>
<td>$6.3</td>
<td>$6.0</td>
<td>$6.3</td>
<td>$28.00</td>
<td>$62.3K</td>
<td>1.2K</td>
<td>51</td>
</tr>
<tr>
<td>MRNA</td>
<td>看涨</td>
<td>交易</td>
<td>中性</td>
<td>02/20/26</td>
<td>$1.65</td>
<td>$1.48</td>
<td>$1.55</td>
<td>$35.00</td>
<td>$46.5K</td>
<td>632</td>
<td>303</td>
</tr>
<tr>
<td>MRNA</td>
<td>看涨</td>
<td>交易</td>
<td>看涨</td>
<td>09/18/26</td>
<td>$6.15</td>
<td>$5.75</td>
<td>$6.15</td>
<td>$32.00</td>
<td>$43.0K</td>
<td>175</td>
<td>70</td>
</tr>
</tbody>
</table>
</div><h3>About Moderna</h3>
<div class="lb-trans"><h3>关于 Moderna</h3>
</div><p>Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.</p>
<div class="lb-trans"><p>Moderna 是一家商业阶段的生物技术公司，成立于 2010 年，并于 2018 年 12 月首次公开募股。该公司的 mRNA 技术在其新冠疫苗中迅速得到验证，该疫苗于 2020 年 12 月在美国获得授权。截至 2025 年 8 月，Moderna 有 35 个 mRNA 开发候选药物处于临床研究阶段。其项目涵盖了广泛的治疗领域，包括传染病、肿瘤学、心血管疾病和罕见遗传疾病。</p>
</div><p>After a thorough review of the options trading surrounding Moderna, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<div class="lb-trans"><p>在对 Moderna 的期权交易进行全面审查后，我们将更详细地审视该公司。这包括对其当前市场状态和表现的评估。</p>
</div><h3>Where Is Moderna Standing Right Now?</h3>
<div class="lb-trans"><h3>Moderna 目前的状况如何？</h3>
</div><ul>
<li>With a volume of 3,654,858, the price of MRNA is up 0.81% at $29.7.</li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 60 days.</li>
</ul>
<div class="lb-trans"><ul>
<li>MRNA 的成交量为 3,654,858，价格上涨 0.81%，达到 29.7 美元。</li>
<li>RSI 指标暗示基础股票可能接近超买状态。</li>
<li>下一次财报预计将在 60 天内发布。</li>
</ul>
</div><h3>What The Experts Say On Moderna</h3>
<div class="lb-trans"><h3>专家对 Moderna 的看法</h3>
</div><p>A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $32.8.</p>
<div class="lb-trans"><p>在过去 30 天内，共有 5 位专业分析师对该股票发表了看法，设定的平均目标价为 32.8 美元。</p>
</div><p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<div class="lb-trans"><p><strong>在短短 20 天内将 1000 美元变成 1270 美元？</strong></p>
</div><p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.
* An analyst from RBC Capital has decided to maintain their Sector Perform rating on Moderna, which currently sits at a price target of $25.
* An analyst from Morgan Stanley persists with their Equal-Weight rating on Moderna, maintaining a target price of $28.
* Maintaining their stance, an analyst from Leerink Partners continues to hold a Underperform rating for Moderna, targeting a price of $18.
* In a cautious move, an analyst from Jefferies downgraded its rating to Hold, setting a price target of $30.
* An analyst from Piper Sandler downgraded its action to Overweight with a price target of $63.</p>
<div class="lb-trans"><p>一位拥有 20 年经验的期权交易员揭示了他的单行图表技术，显示何时买入和卖出。复制他的交易，平均每 20 天获得 27% 的利润。点击这里获取访问权限。
* RBC Capital 的一位分析师决定维持对 Moderna 的行业表现评级，目前目标价为 25 美元。
* 摩根士丹利的一位分析师继续维持对 Moderna 的均衡评级，目标价为 28 美元。
* Leerink Partners 的一位分析师维持对 Moderna 的表现不佳评级，目标价为 18 美元。
* Jefferies 的一位分析师谨慎地将其评级下调至持有，目标价为 30 美元。
* Piper Sandler 的一位分析师将其评级下调至超配，目标价为 63 美元。</p>
</div><p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Moderna with Benzinga Pro for real-time alerts.</p>
<div class="lb-trans"><p>交易期权涉及更大的风险，但也提供了更高的利润潜力。精明的交易者通过持续教育、战略交易调整、利用各种指标以及关注市场动态来降低这些风险。通过 Benzinga Pro 获取 Moderna 最新期权交易的实时警报。</p>
</div>

Moderna 期权交易：深入分析市场情绪